BANK OF AMERICA CORP /DE/ - LANTERN PHARMA INC ownership

LANTERN PHARMA INC's ticker is LTRN and the CUSIP is 51654W101. A total of 26 filers reported holding LANTERN PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of LANTERN PHARMA INC
ValueSharesWeighting
Q4 2022$488
-38.5%
0.00%
Q4 2021$0
-100.0%
13
-99.8%
0.00%
Q3 2021$62,000
+93.8%
5,603
+155.7%
0.00%
Q2 2021$32,000
+3100.0%
2,191
+5377.5%
0.00%
Q1 2021$1,000400.00%
Other shareholders
LANTERN PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
SANDERS MORRIS HARRIS LLC 365,930$1,721,0000.42%
CM Management, LLC 50,000$239,0000.27%
WOLFF WIESE MAGANA LLC 30,462$146,0000.12%
Redmond Asset Management, LLC 49,502$237,0000.09%
CARLSON CAPITAL L P 168,000$803,0000.06%
NewEdge Advisors, LLC 171,019$817,0000.01%
Sigma Planning Corp 17,500$84,0000.00%
WELLS FARGO & COMPANY/MN 3,984$19,0000.00%
NORTHERN TRUST CORP 12,629$60,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of LANTERN PHARMA INC shareholders